Search Within

Marinela Capanu

Formats
  1. Journal Article (232)
  2. Meeting Abstract (158)
  3. Correspondence (3)
  4. Miscellaneous (1)
Groups
  1. Biostatistics Service (394)
  2. Center for Pancreatic Cancer Research (394)
  3. Epidemiology and Biostatistics (394)
  4. Department of Medicine (313)
  5. Solid Tumor Oncology Division (310)
  6. Gastrointestinal Oncology Service (280)

More Groups

People
  1. Joanne Chou (167)
  2. David Kelsen (98)
  3. Eileen O'Reilly (97)
  4. Ghassan Abou-Alfa (67)
  5. David Ilson (65)
  6. Yelena Janjigian (61)

More People

Years
  1. 2025 (17)
  2. 2024 (23)
  3. 2023 (21)
  4. 2022 (24)
  5. 2021 (24)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (147)
  2. Cancer (18)
  3. Annals of Oncology (15)
  4. Abdominal Radiology (14)
  5. Clinical Cancer Research (12)
  6. Annals of Surgical Oncology (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (152)
  2. Springer (42)
  3. Wiley Blackwell (31)
  4. Oxford University Press (29)
  5. Elsevier Inc. (21)
  6. Lippincott Williams & Wilkins (21)

More Publishers

Results (394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report
    Journal Article

    Bernstein, J. L.; Thomas, D. C.; Shore, R. E.; Robson, M.; Boice, J. D. Jr; Stovall, M.; Andersson, M.; Bernstein, L.; Malone, K. E.; Reiner, A. S.; more...
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics and survival outcomes of patients with Fibrolamellar carcinoma: Data from the Fibrolamellar Carcinoma consortium
    Journal Article

    Ang, C. S.; Kelley, R. K.; Choti, M. A.; Cosgrove, D. P.; Chou, J. F.; Klimstra, D.; Torbenson, M. S.; Ferrell, L.; Pawlik, T. M.; Fong, Y.; more...
    Gastrointestinal Cancer Research (2013)

    Fulltext@MSK | Save
  • Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study
    Journal Article

    Reiner, A. S.; John, E. M.; Brooks, J. D.; Lynch, C. F.; Bernstein, L.; Mellemkjær, L.; Malone, K. E.; Knight, J. A.; Capanu, M.; Teraoka, S. N.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Is conversion to resection possible with hepatic arterial infusion (HAI) and systemic (SYS) even in previously treated patients (pts) with unresectable colorectal liver metastases (UnCLM)?
    Meeting Abstract

    Kemeny, N. E.; Fong, Y.; Paty, P.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Jarnagin, W. R.; DeMatteo, R. P.; Allen, P. J.; Kingham, T. P.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I trial of yttrium 90 resin microspheres in the treatment of colon cancer liver metastases progressing despite hepatic arterial as well as systemic chemotherapy: Preliminary results
    Meeting Abstract

    Sofocleous, C. T.; Kemeny, N. E.; Pandit-Taskar, N.; Do, K. G.; Brody, L. A.; Garcia, A. R.; Capanu, M.; Chou, J. F.; Petre, E. N.; Carrasquillo, J. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Effects of radiologic tumor response of anti-glypican-3 GC33 and multi tyrosine kinases inhibitor sorafenib in hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Zhao, B.; Chou, J. F.; Ma, J.; Capanu, M.; Koga, M.; Lee, R.; Othomo, T.; Germino, J.; Schwartz, L.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma
    Journal Article

    Ang, C.; O'Reilly, E. M.; Carvajal, R. D.; Capanu, M.; Gonen, M.; Doyle, L.; Ghossein, R.; Schwartz, L.; Jacobs, G.; Ma, J.; more...
    Gastrointestinal Cancer Research (2012)

    Fulltext@MSK | Save
  • Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study
    Journal Article

    Brooks, J. D.; Boice, J. D. Jr; Stovall, M.; Reiner, A. S.; Bernstein, L.; John, E. M.; Lynch, C. F.; Mellemkjær, L.; Knight, J. A.; Thomas, D. C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save